IgG1 glycosylation highlights premature aging in Down syndrome
Aging Cell · 2024
DOI: 10.1111/acel.14167 ↗At a glance
Journal article in Aging Cell, 2024. Written by Bianca M M Streng and 13 co-authors. Institution: Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherla…. Major MEDLINE topics: Immunoglobulin G, Aging, Premature, Down Syndrome. Cited 6 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: ZonMw, Landsteiner Foundation for Blood Transfusion Research.
Abstract (original language)
Down syndrome (DS) is characterized by lowered immune competence and premature aging. We previously showed decreased antibody response following SARS‐CoV‐2 vaccination in adults with DS. IgG1 Fc glycosylation patterns are known to affect the effector function of IgG and are associated with aging. Here, we compare total and anti‐spike (S) IgG1 glycosylation patterns following SARS‐CoV‐2 vaccination in DS and healthy controls (HC). Total and anti‐Spike IgG1 Fc N ‐ glycan glycoprofiles were measured in non‐exposed adults with DS and controls before and after SARS‐CoV‐2 vaccination by liquid chromatography–mass spectrometry (LC–MS) of Fc glycopeptides. We recruited N = 44 patients and N = 40 controls. We confirmed IgG glycosylation patterns associated with aging in HC and showed premature aging in DS. In DS, we found decreased galactosylation (50.2% vs. 59.0%) and sialylation (6.7% vs. 8.5%) as well as increased fucosylation (97.0% vs. 94.6%) of total IgG. Both cohorts showed similar bisecting GlcNAc of total and anti‐S IgG1 with age. In contrast, anti‐S IgG1 of DS and HC showed highly comparable glycosylation profiles 28 days post vaccination. The IgG1 glycoprofile in DS exhibits strong premature aging. The combination of an early decrease in IgG1 Fc galactosylation and sialylation and increase in fucosylation is predicted to reduce complement activity and decrease FcγRIII binding and subsequent activation, respectively. The altered glycosylation patterns, combined with decreased antibody concentrations, help us understand the susceptibility to severe infections in DS. The effect of premature aging highlights the need for individuals with DS to receive tailored vaccines and/or vaccination schedules.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
- Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
- Centre for Immunology of Infectious Diseases and Vaccines, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
ORCID profiles: Bianca M M Streng
Funding
- ZonMw
- Landsteiner Foundation for Blood Transfusion Research
Cite
APA
Streng, B. M. M., Van Coillie, J., Wildenbeest, J. G., Binnendijk, R. S., Smits, G., den Hartog, G., Wang, W., Nouta, J., Linty, F., Visser, R., Wuhrer, M., Vidarsson, G., Bont, L. J., & PRIDE study group (2024). IgG1 glycosylation highlights premature aging in Down syndrome. Aging Cell. https://doi.org/10.1111/acel.14167
Vancouver
Streng BMM, Van Coillie J, Wildenbeest JG, Binnendijk RS, Smits G, den Hartog G, et al. IgG1 glycosylation highlights premature aging in Down syndrome. Aging Cell. 2024. doi:10.1111/acel.14167
BibTeX
@article{Streng2024,
author = {Streng, Bianca M M and Van Coillie, Julie and Wildenbeest, Joanne G and Binnendijk, Rob S and Smits, Gaby and den Hartog, Gerco and Wang, Wenjun and Nouta, Jan and Linty, Federica and Visser, Remco and Wuhrer, Manfred and Vidarsson, Gestur and Bont, Louis J and PRIDE study group, PRIDE study group},
title = {IgG1 glycosylation highlights premature aging in Down syndrome},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14167}
}
EUVIMED